产品编号 :
Cas No. :
CAS No. |
253426-24-3 |
|---|---|
中文名称 |
奥姆布拉布林盐酸盐 |
英文名称 |
Ombrabulin HCl |
别名 |
Ombrabulin hydrochloride (JAN) | SCHEMBL1419930 | CPMO | AC7700 (hydrochloride) | AVE8062 (hydrochloride) | (z)-N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl] phenyl]-l-serinamide hydrochloride | PB42394 | OMBRABULIN HYDROCHLORIDE [JAN] | PROPANAMIDE, 2 |
标准英文名 |
(S,Z)-2-amino-3-hydroxy-N-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)propanamide hydrochloride |
MDL No. |
MFCD04307816 |
分子式 |
C21H27ClN2O6 |
分子量 |
438.91 |
精确分子量 |
438.16 |
SMILES |
O=C(NC1=CC(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC)[C@@H](N)CO.[H]Cl |
标准SMILES |
Cl.COC1C=C(C=C(OC)C=1OC)/C=C\C1C=C(NC(=O)[C@@H](N)CO)C(=CC=1)OC |
用途 |
Ombrabulin hydrochloride is a derivative of CA-4 phosphate that selectively disrupts the tubulin cytoskeleton in endothelial cells, exhibiting anti-angiogenic activity; it demonstrates potent cytotoxic effects against both endothelial and tumor cells in vitro, with IC50 values ranging from 7 to 20 nM in various tumor cell lines (HeyA8, SKOV3ip1, and HeyA8-MDR) and 10 nM in mouse mesenteric endothelial cells (MMEC); in combination with Docetaxel, it significantly enhances cytotoxicity (2- to 4-fold) compared to either agent alone; in vivo, it shows antitumor efficacy in a HeyA8 ovarian cancer xenograft model in nude mice, reducing tumor weight by 65% at a dose of 30 mg/kg (administered twice weekly via intraperitoneal injection for 3 weeks) compared to vehicle control. |
InChIKey |
UQNRTPFLTRZEIM-MRWUDIQNSA-N |
|
|
评论 |
|---|